News

The Drug Enforcement Administration and Department of Health and Human Services yesterday announced that the effective date for the final rule regarding telemedicine prescribing of buprenorphine will be further delayed from March 21 to Dec. 31.

There are 378 confirmed cases of measles in 17 states across the country, according to the latest data from the Centers for Disease Control and Prevention.

The Food and Drug Administration has identified a Class I recall of Becton, Dickinson and Company BD Alaris Systems Manager and BD Care Coordination Engine Infusion Adapters due to reports that customers using Systems Manager software who are also connected to the system’s CCE Infusion Adapter may experience delayed system response and backlogging of automated programming requests.

America’s hospitals and health systems are incubators of innovation, ideas and medical progress as they are constantly striving to improve patient care and advance health.

The Equal Employment Opportunity Commission and the Department of Justice March 19 announced the release of two documents warning against unlawful discrimination related to diversity, equity and inclusion in the workplace.

A JAMA Network Open study published March 13 found that 90% of Medicaid managed care plans cover at least one alcohol use disorder medication without prior authorization and quantity limits.

The International Hospital Federation is accepting nominations through May 2 for its 2025 awards honoring excellence in hospitals and health care organizations globally.

The Food and Drug Administration March 20 issued an alert on a potentially high-risk issue with Calyxo CVAC Aspiration Systems.

The Department of Health and Human Services yesterday announced that it renewed the public health emergency for the nation’s opioid crisis an additional 90 days.

There have been 301 confirmed cases of measles across the U.S. so far this year, surpassing the 2024 total of 285, according to the latest data from the Centers for Disease Control and Prevention.

The U.S. birth rate fell 2% in 2023 to about 3.6 million, according to final data released March 18 by the Centers for Disease Control and Prevention.

The Food and Drug Administration has identified a Class I recall of Medtronic Neurovascular 027 Compatible Pipeline Vantage Embolization Devices due to reports of a higher incidence of the flexible, braided tube part of the device failing to properly attach or stay attached to the blood vessel wall during and after procedures.

The AHA March 18 commented on the Drug Enforcement Administration's proposed rule for special registrations for telemedicine prescribing of controlled substances.

The Food and Drug Administration March 14 released a notice on a nationwide shortage of hemodialysis tubes expected to last through early fall.

A ChatGPT vulnerability identified last year is being used by cyberthreat actors to attack security flaws in artificial intelligence systems, according to a March 12 report by Veriti, a cybersecurity firm.

A new initiative launched March 18 by the Dr. Lorna Breen Heroes' Foundation seeks to improve mental health care access for health care workers.

The Medicaid and CHIP Payment and Access Commission released its March 2025 report to Congress March 13.

The U.S. Attorney’s Office for the District of New Jersey March 13 announced charges for Rostislav Panev, a dual Russian and Israeli national, for his alleged role as a developer of the LockBit ransomware group.

The Department of Health and Human Services said its decision to prevent drug companies from implementing a 340B rebate model “was within its statutory authority,” according to a department brief filed March 17 with the United States District Court for the District of Columbia.

Americans' assessments of their mental and physical health are the least positive they have been in the history of Gallup’s 24-year poll on the subject, with just 75% and 76% respectively rating their mental and physical health as “excellent” or “good” according its latest survey released March 13.